Asymptomatic bacteriuria in pregnancy: evolution of generally accepted views


DOI: https://dx.doi.org/10.18565/therapy.2020.1.104-111

Volgina G.V., Frolova N.F.

1) A.I. Yevdokimov Moscow State University of medicine and dentistry of the Ministry of Healthcare of Russia; 2) City clinical hospital No 52 of the Department of Healthcare of Moscow
Asymptomatic bacteriuria is a microbiological diagnosis, often found in a female population, but its prevalence varies widely depending on age, sexual activity, the presence of urogenital disorders and concomitant diseases. When detecting BB during pregnancy, the doctor always raises the question of the need and timing of bacteriological examination of urine, its clinical significance, and the relationship with obstetric and perinatal complications. In accordance with numerous international recommendations, antibacterial therapy of ВВ in pregnant women is a standard procedure. In recent years, based on the results of clinical trials and practical experience, there has been a wide discussion about the clinical relevance of antibiotic therapy for BB in all pregnant women, regardless of the presence of risk factors. The article provides a review of the literature and existing international and national recommendations on epidemiology, a description of the main causative agents of BB, diagnostic criteria, management of pregnant women with BB, and antibiotic treatment regimens.
Keywords: pregnancy, asymptomatic bacteriuria, urinary tract infection, diagnosis, treatment
Read entire article

Literature


  1. Nicolle L.E., Gupta K., Bradley S.F., Colgan R., DeMuri G.P., Drekonja D., Eckert L.O., Geerlings S.E., Köves B., Hooton T.M., Juthani-Mehta M., Knight S.L., Saint S., Schaeffer A.J., Trautner B., Wullt B., Siemieniuk R. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa. Clin Infect Dis. 2019; 68(10): e83–e110. doi: 10.1093/cid/ciy1121.

  2. Glaser A.P., Schaeffer A.J. Urinary tract infection and bacteriuria in pregnancy. Urol Clin North Am. 2015; 42(4): 547–60.doi: https://doi.org/10.1016/j.ucl.2015.05.004.

  3. Hilt E.E., McKinley K., Pearce M.M., Rosenfeld A.B., Zilliox M.J., Mueller E.R., Brubaker L., Gai X., Wolfe A.J., Schreckenberger P.C. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014; 52(3): 871–76. doi: 10.1128/JCM.02876-13.

  4. Finucane T. E. «Urinary tract infection» –requiem for a heavyweight. J Am Geriatr Soc. 2017; 65(8): 1650–55.doi: 10.1111/jgs.14907.

  5. Grabe M. (Chair), Bartoletti R., Bjerklund Johansen T.E., Cai T., Çek M., Köves B., Naber K.G., Pickard R.S., Tenke P., Wagenlehner F., Wullt B. Guidelines on urological infections European Association of Urology, 2015. http://uroweb.org/wp-content//uploads/19-Urological-infections.

  6. Палагин И.С., Сухорукова М.В., Дехнич А.В., Эйдельштейн М.В., Шевелев А.Н., Гринев А.В., Перепанова Т.С., Козлов Р.С. Современное состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты исследования «ДАРМИС» (2010–2011). Клиническая микробиология и антимикробная химиотерапия. 2012; 14(4): 280–302. [Palagin I.S. et al. Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia: «DARMIS» Study (2010–2011). 2012; 14(4): 280–302 (In Russ.)].

  7. Sunden F., Hakansson L., Ljunggren E., Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J. Urol. 2010, 184(1): 179–85. doi: 10.1016/j.juro.2010.03.024.

  8. Nicolle L.E. Asymptomatic bacteriuria. Curr. Opin. Infect. Dis. 2014; 27(1): 90–96. doi: 10.1097/QCO.0000000000000019.

  9. Zdziarski J., Brzuszkiewicz E., Wullt B., Liesegang H., Biran D., Voigt B., Grönberg-Hernandez J., Ragnarsdottir B., Hecker M., Ron E.Z., Daniel R., Gottschalk G., Hacker J., Svanborg C., Dobrindt U. Host imprints on bacterial genomes--rapid, divergent evolution in individual patients. PLoS Pathog. 2010; 6(8): e1001078. doi: 10.1371/journal.ppat.1001078.

  10. Nienhouse V., Gao X., Dong Q., Nelson D.E., Toh E., McKinley K., Schreckenberger P., Shibata N., Fok C.S., Mueller E.R., Brubaker L., Wolfe A.J., Radek K.A. Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity. PLoS One. 2014; 9(12): e114185.

  11. Brubaker L., Wolfe A. The urinary microbiota: a paradigm shift for bladder disorders? Curr Opin Obstet Gynecol, 2016; 28(5): 407–12.

  12. Kass E.H. Pyelonephritis and Bacteriuria. A Major Problem in Preventive Medicine. Annals of Internal Medicine. 1962; 56: 46–53. doi: https://doi.org/10.7326/0003-4819-56-1-46.

  13. Lumbiganon P., Laopaiboon M., Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol. 2010; 22(2): 95–99. doi: 10.1097/GCO.0b013e3283374adf.

  14. Wing D.A., Fassett M.J., Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol. 2014; 210: 219.e1-6. doi: 10.1016/j.ajog.2013.10.006.

  15. Ipe D.S., Sundac L., Benjamin W.H. Jr., Moore K.H. Asymptomatic bacteriuria: prevalence rates of causal microorganisms, etiology of infection in different patient populations, and recent advances in molecular detection. FEMS Microbiol letters. 2013; 346(1): 1–10. doi: 10.1111/. 1574-6968.12204

  16. Smaill F.M., Vazquez J.C. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2015; 7(8): CD000490. doi: 10.1002/14651858.

  17. Moore А., Doull М., Grad R., Groulx S., Pottie K., Tonelli M., Courage S., Garcia A.J., Thombs B.D. Recommendations on screening for asymptomatic bacteriuria in pregnancy. For the Canadian Task Force on Preventive Health Care. CMAJ. 2018; 190(27): E823–30. doi: 10.1503/cmaj.171325.

  18. Renko M., Tapanainen P., Tossavainen, P., Pokka T., Uhari M. Metaanalysis of the significance of asymptomatic bacteriuria in diabetes. Diabetes Care. 2011; 34, 230–35. https://doi.org/10.2337/dc10-0421.

  19. Kazemier B.M., Koningstein F.N., Schneeberger C., Ott A., Bossuyt P.M., de Miranda E., Vogelvang T.E., Verhoeven C.J., Langenveld J., Woiski M., Oudijk M.A., van der Ven J.E., Vlegels M.T., Kuiper P.N., Feiertag N., Pajkrt E., de Groot C.J., Mol B.W., Geerlings S.E. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis. 2015; 15(11): 1324–33.doi: 10.1016/S1473-3099(15)00070-5.

  20. Angelescu K., Nussbaumer-Streit B., Sieben W., Scheibler F., Gartlehner G. Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review. BMC Pregnancy Childbirth. 2016; 16(1): 336.doi: 10.1186/s12884-016-1128-0.

  21. Wright A.J., Unger S., Coleman B.L., Lam P.P., McGeer A.J. Maternal antibiotic exposure and risk of antibiotic resistance in neonatal early-onset sepsis: a case-cohort study. Pediatr Infect Dis J. 2012; 31: 1206–08. doi: 10.1097/INF.0b013e31826eb4f9.

  22. Nordeng H., Lupattelli A., Romøren M., Koren G. Neonatal outcomes after gestational exposure to nitrofurantoin. Obstet Gynecol 2013; 121: 306–13. doi: http://10.1097/AOG.0b013e31827c5f88.

  23. Nicolle L.E., Bradley S., Colgan R., Rice J.C., Schaeffer A., Hooton T.M. Infectious Diseases Society of America guidelines for the diagnosis and treatment bacteriuria in adults. Clin. Infect. Dis. 2005; 40(5): 643–54.

  24. Bonkat G., Pickard R., Bartoletti R., Cai T., Bruyère F., Geerlings S.E., Köves B., Wagenlehner F., Pilatz A., Pradere B., Veeratterapillay R. European Association of Urology. EAU Guidelines urological infections; update 2019;https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urological-infections-2019.pdf

  25. Koves B., Cai T., Veeratterapillay R., Pickard R., Seisen T., Lam T.B. et al. Benefits and harms of treatment of asymptomatic bacteriuria: a systematic review and meta-analysis by the European Association of Urology Urological Infection Guidelines Panel. Eur. Urol. 2017; 72(6): 865–68. doi: 10.1016/j.eururo.2017.07.014.

  26. Wingert A., Pillay J., Sebastianski M., Gates M., Featherstone R., Shave K., Vandermeer B., Hartling L. Asymptomatic bacteriuria in pregnancy: systematic reviews of screening and treatment effectiveness and patient preferences. BMJ Open. 2019; 9: e021347. doi: 10.1136/bmjopen-2017-021347

  27. Nicolle L.E. The paradigm shift to non-treatment of asymptomatic bacteriuria. Pathogens. 2016; 5(2): E38–44.doi: 10.3390/pathogens5020038.

  28. Brubaker L., Wolfe A. The urinary microbiota: a paradigm shift for bladder disorders? Curr Opin Obstet Gynecol, 2016; 28(5): 407–12. doi: 10.1097/GCO.0000000000000298.

  29. Захарова И.Н., Османов И.М., Мачнева Е.Б., Мумладзе Э.Б., Касьянова А.Н., Айсанова М.Р. От бактериурии до микробиома мочевых путей: эволюция взглядов ученых и клиницистов. Медицинский совет. 2018; 17: 168–176. [Zakharova I.N., Osmanov I.M., Machneva E.В., Mumladze Е.B., Kasyanova A.N., Aisanova M.Р. From bacteriuria to the urinary tract microbiome: the evolution of the views of researchers and clinicians. Medicinskiy sovet. 2018; 17: 168–176 (In Russ)].doi: https://doi.org/10.21518/2079-701X-2018-17-168-176.

  30. Alvarez J.R., Fechner A.J., Williams S.F., Ganesh V.L., Apuzzio J.J. Asymptomatic bacteriuria in pregestational diabetic pregnancies and the role of group B streptococcus. Am J Perinatol. 2010; 27(3): 231–34. doi: 10.1055/s-0029-1239485.

  31. Nicolle L.E., Gupta K., Bradley S.F., Colgan R., G.P. DeMuri, Drekonja D., Eckert L.O., Geerlings S.E., Köves B., Hooton T.M., Juthani-Mehta M., Knight S.L., Saint S., Schaeffer A.J., Trautner B., Wullt B., Siemieniuk R. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2019; 68(10): e83–е110. doi: https://doi.org/10.1093/cid/ciy1121

  32. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М.; 2017.

  33. Урология/российские клинические рекомендации. Под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря. М.: ГЭОТАР-Медиа; 2017. 544 с.

  34. Волгина Г.В. Бессимптомная бактериурия – современная тактика диагностики и лечения. Нефрология и диализ. 2012; 14(1): 6–14. [Volgina G.V. Asymptomatic bacteriuria: modern management and treatment. Nephrologiya i dializ. 2012; 14(1): 6–14 (In Russ.)].


About the Autors

Galina V. Volgina, MD, professor, professor of the Department of nephrology of faculty of additional professional education of A.I. Yevdokimov Moscow State University of medicine and dentistry of the Ministry of Healthcare of Russia. Address: 127473, Moscow, 20/1 Delegatskaya Str. Tel.: +7 (499) 196-10-11; 8 (985)-281-90-07. E-mail: Volginagv@mail.ru
Nadiya F. Frolova, deputy Chief Doctor of nephrologic medical care of City clinical hospital No 52 of the Department of Healthcare of Moscow. Address: 123182, Moscow, 3 Pekhotnaya Str. Tel.: +7 (905) 728-63-96. E-mail: nadiya.frolova@yandex.ru


Similar Articles

Back to Content

Бионика Медиа